Resolution Therapeutics Announces £63.5 Million Series B …
Oct 3, 2024 · Resolution Therapeutics Announces New Clinical and Preclinical Data Showcasing Regenerative Macrophage Therapy at AASLD The Liver Meeting® 2024 to Support the …
OFF
Resolution Therapeutics Announces £63.5 Million Series B …
6 days from now
Oct 3, 2024 · Resolution Therapeutics Announces New Clinical and Preclinical Data Showcasing Regenerative Macrophage Therapy at AASLD The Liver Meeting® 2024 to Support the …
prnewswire.com
OFF
Resolution Therapeutics Announces £63.5 Million Series B …
6 days from now
Oct 3, 2024 · Resolution Therapeutics Limited ("Resolution"), a clinical-stage biopharmaceutical company focused on unlocking the regenerative potential of macrophage therapy for the …
yahoo.com
OFF
Resolution Therapeutics Announces Approval Of Clinical Trial ...
6 days from now
4 days ago · Resolution Therapeutics Announces £63.5 Million Series B Financing and Chair Appointment Resolution Therapeutics Limited ("Resolution"), a clinical-stage …
prnewswire.com
OFF
Resolution Therapeutics Announces £63.5 Million Series B …
6 days from now
Oct 3, 2024 · Edinburgh and London, UK, 3 October 2024 – Resolution Therapeutics Limited (“Resolution”), a clinical-stage biopharmaceutical company focused on unlocking the …
resolution-tx.com
OFF
Resolution Therapeutics Announces New Clinical And Preclinical …
6 days from now
Nov 11, 2024 · Resolution Therapeutics Announces £63.5 Million Series B Financing and Chair Appointment Resolution Therapeutics Limited ("Resolution"), a clinical-stage …
prnewswire.com
OFF
Edinburgh Innovations | Spinout Resolution Therapeutics …
6 days from now
Jun 5, 2024 · Biotech spinout Resolution Therapeutics has announced it has raised £63.5 million in a series B financing round led by healthcare investor Syncona Ltd. The company, founded …
ed.ac.uk
OFF
Resolution Therapeutics Announces £63.5 Million Series B …
6 days from now
Oct 3, 2024 · Resolution Therapeutics Announces £63.5 Million Series B Financing and Chair Appointment. Financing to advance lead asset RTX001, an engineered, pro-regenerative …
streetinsider.com
OFF
Resolution Therapeutics Raises £63.5M In Series B Financing
6 days from now
October 3, 2024. Resolution Therapeutics, an Edinburgh, Scotland, and London, UK-based clinical-stage biopharmaceutical company, raised £63.5M in Series B funding. The round was …
finsmes.com
OFF
Resolution Therapeutics Raises £63.5 Million In Series B Financing …
6 days from now
Oct 3, 2024 · The Series B financing brings the total amount raised by Resolution to £101.4 million. Following the drawdown of the full Series B financing, Syncona's ownership stake in …
pharmiweb.com
OFF
Resolution Therapeutics Announces £63.5 Million Series B …
6 days from now
Oct 3, 2024 · EDINBURGH, Scotland and LONDON, Oct. 3, 2024 /PRNewswire/ — Resolution Therapeutics Limited (“Resolution”), a clinical-stage biopharmaceutical company focused on …
stockstreetnews.com
OFF
Edinburgh’s Resolution Therapeutics Raises £63m
6 days from now
Oct 3, 2024 · Edinburgh-based Resolution Therapeutics Limited announced it has raised £63.5 million in Series B financing round led by investment firm Syncona Ltd. Resolution is a clinical …
scottishfinancialreview.com
OFF
Edinburgh HQ'd Resolution Therapeutics Announced A £63.5M …
6 days from now
Oct 9, 2024 · Edinburgh HQ'd Resolution Therapeutics announced a £63.5M series B this month to advance its pro-regenerative macrophage therapy into further end-stage liver disease …
biotechtv.com
OFF
Resolution’s £64M Series B To Advance Macrophage Cell Therapy
6 days from now
Oct 3, 2024 · A preview of the next edition of BioWorld, Oct. 3, 2024. Resolution Therapeutics Ltd. is preparing for a phase I/II trial of its autologous engineered macrophage cell therapy, RTX …
bioworld.com
OFF
Resolution Therapeutics Announces £63.5 Million Series B …
6 days from now
Oct 3, 2024 · EDINBURGH, Scotland and LONDON, Oct. 3, 2024 /PRNewswire/ -- Resolution Therapeutics Limited ("Resolution"), a clinical-stage biopharmaceutical company focused on …
epicos.com
OFF
Series B - Resolution Therapeutics - 2024-10-03 - Crunchbase
6 days from now
Oct 3, 2024 · Resolution Therapeutics raised $29147914 on 2024-10-03 in Series B. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. Resources. Pricing. …
crunchbase.com
OFF
Resolution Therapeutics Announces £63.5 Million Series B …
6 days from now
Oct 4, 2024 · Resolution Therapeutics Limited (“Resolution”), a clinical-stage biopharmaceutical company focused on unlocking the regenerative potential of macrophage therapy for the …
pharmajournalist.com
OFF
Resolution’s £64M Series B To Advance Macrophage Cell Therapy
6 days from now
Oct 3, 2024 · Resolution Therapeutics Ltd. is preparing for a phase I/II trial of its autologous engineered macrophage cell therapy, RTX-001, in the treatment of end-stage liver disease …
bioworld.com
FAQs about Resolution Therapeutics Announces £63.5 Million Series B … Coupon?
What is resolution Therapeutics?
Is resolution a regenerative biopharmaceutical company?
How much did resolution raise in Series B financing?
Will rtx001 go into clinical trials?
Who financed rtx001?
What is resolution's lead candidate therapy?
Install CouponFollow Extension on Chrome
Install the CouponFollow extension to search for discount codes when shopping the fastest!
Install CouponFollow Chrome Extension
Listing Store by Characters
